Zerbor DermTech (NASDAQ:DMTK) stock plummeted ~32% after Q2 net loss widened and the company lowered its FY22 assay revenue outlook.
An aerial view of buildings destroyed by Israeli airstrikes in the Jabalia camp for Palestinian refugees in Gaza City on